`

Cellectis

Biotechnology Research

Specialities :
Gene editing
Life sciences
Oncology
T-cell therapies
Genome engineering

+2

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
201 - 500

Frequently Asked Questions About Cellectis

What does Cellectis do?+

Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 24 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address...

What are Cellectis's specialties? +

Gene editing,life sciences,oncology,t-cell therapies,genome engineering,allogeneic,and off-the-shef cart therapies

What is Cellectis's industry? +

Cellectis operates in the Biotechnology research industry.

What is Cellectis's revenue? +

Cellectis's revenue is 11m - 100m

What is Cellectis's company size? +

Cellectis has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.